Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 16, 2021 - Issue
Submit an article Journal homepage
187
Views
6
CrossRef citations to date
0
Altmetric
Original Research

A Real World Study to Assess the Effectiveness of Switching to Once Daily Closed Triple Therapy from Mono/Dual Combination or Open Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease

Wei-Chun Huang1 Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan;2 School of Medicine, College of Medicine, China Medical University, Taichung, TaiwanView further author information
,
Chih-Yu Chen1 Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, Taichung, TaiwanView further author information
,
Wei-Chih Liao1 Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan;2 School of Medicine, College of Medicine, China Medical University, Taichung, TaiwanView further author information
,
Biing-Ru Wu1 Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan;3 Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan;4 Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, TaiwanORCID Iconhttps://orcid.org/0000-0002-2824-4387View further author information
ORCID Icon,
Wei-Chun Chen1 Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan;3 Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan;4 Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, TaiwanORCID Iconhttps://orcid.org/0000-0002-8611-605XView further author information
ORCID Icon,
Chih-Yen Tu1 Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan;2 School of Medicine, College of Medicine, China Medical University, Taichung, TaiwanView further author information
,
Chia-Hung Chen1 Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan;2 School of Medicine, College of Medicine, China Medical University, Taichung, TaiwanORCID Iconhttps://orcid.org/0000-0003-1158-9722View further author information
ORCID Icon &
Wen-Chien Cheng1 Division of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan;2 School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan;3 Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan;4 Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, TaiwanCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-8126-6171View further author information
ORCID Icon show all
Pages 1555-1568 | Published online: 03 Jun 2021

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Enrico de Nigris, Catrin Treharne, Nick Brighton, Ulf Holmgren, Andrew Walker & John Haughney. (2022) Cost-Effectiveness of Triple Therapy with Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate versus Dual Therapies in Moderate-to-Very Severe Chronic Obstructive Pulmonary Disease: United Kingdom Analysis Using the ETHOS Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2987-3000.
Read now
Mario Cazzola, Paola Rogliani, Rossella Laitano, Luigino Calzetta & Maria Gabriella Matera. (2022) Beyond Dual Bronchodilation – Triple Therapy, When and Why. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 165-180.
Read now
Mario Cazzola, Paola Rogliani, Luigino Calzetta, Josuel Ora & Maria Gabriella Matera. (2022) A single inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol for the treatment of COPD. Expert Review of Clinical Pharmacology 15:3, pages 269-283.
Read now

Articles from other publishers (3)

Roland Buhl, Michael Dreher, Muriel Mattiucci-Guehlke, Rachel Emerson-Stadler, Sebastian Eckhardt, Christian Taube & Claus F. Vogelmeier. (2023) EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS. Advances in Therapy 40:7, pages 3263-3278.
Crossref
I. Yu. Vizel, I. N. Salakhova, A. A. Vizel, G. R. Shakirova, E. Z. Kudryavtseva & A. R. Vafina. (2022) Peripheral blood eosinophil count in COPD: literature data and new findings. PULMONOLOGIYA 32:1, pages 68-76.
Crossref
Wei Cheng, Jiaxi Duan, Aiyuan Zhou, Yiyang Zhao, Rong Yi, Yi Liu, Dingding Deng, Xin Li, Yuqin Zeng, Yating Peng, Qing Song, Ling Lin, Min Yang & Ping Chen. (2021) Real-World Effectiveness of Inhalation Therapy Among Patients With Symptomatic COPD in China: A Multicenter Prospective Study. Frontiers in Pharmacology 12.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.